시장보고서
상품코드
1939296

심방세동 디바이스 시장 보고서(2026년)

Atrial Fibrillation Devices Global Market Report 2026

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

심방세동 치료 기기 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 86억 달러에서 2026년에는 96억 1,000만 달러로, CAGR 11.7%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 심방세동 유병률 증가, 고령 인구 증가, 심혈관 질환 부담 증가, 전기생리검사실 확대, 이식형 심장장치의 보급에 기인하는 것으로 추정됩니다.

심방세동 치료 디바이스 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 147억 7,000만 달러에 달하며, CAGR은 11.3%에 달할 전망입니다. 예측 기간의 성장 요인으로는 절제술 기술의 발전, 원격 환자 모니터링의 보급 확대, 뇌졸중 예방에 대한 의식의 향상, 외래수술센터(ASC)의 확대, 매핑 및 내비게이션 시스템의 기술 혁신 등을 꼽을 수 있습니다. 예측 기간 중 주요 동향으로는 카테터 절제술의 채택 증가, 웨어러블 및 원격 심전도 모니터링 장치의 사용 확대, 저침습적 심방세동 치료법에 대한 수요 증가, 좌심실 폐쇄장치의 사용 확대, 조기 발견 및 장기적인 리듬 모니터링에 대한 집중도 강화 등이 있습니다.

심혈관 질환 증가 추세는 향후 수년간 심방세동 치료 기기 시장의 성장을 가속할 것으로 예측됩니다. 심혈관질환이란 심장마비, 뇌졸중, 고혈압 등 심장과 혈관에 영향을 미치는 질환군을 말합니다. 이러한 질병 증가는 주로 전 세계 비만율과 당뇨병 증가, 그리고 앉아서 생활하는 습관과 건강에 해로운 식습관에 기인합니다. 심방세동(AFib) 장치는 기저 심장질환과 관련이 있는 부정맥을 감지, 모니터링, 치료함으로써 심혈관 질환 관리에 필수적인 역할을 합니다. 예를 들어 2024년 6월 미국 공중보건기관인 미국심장협회가 발표한 보고서에 따르면 고혈압 유병률이 51.2%에서 61.0%로 증가할 것으로 예측되는 가운데, 심혈관 질환으로 진단받은 환자 수는 2020년 1억 2,800만 명에서 2050년까지 1억 8,400만 명 이상으로 증가할 것으로 예측됩니다. 이처럼 심혈관 질환 발생률 증가는 심방세동 치료기기 시장 확대에 기여하고 있습니다.

심방세동 치료 기기 시장의 주요 기업은 진단 정확도 향상, 치료 전략 맞춤화, 환자 결과 개선을 위한 환자 중심의 임상 의사결정 지원 툴 등 기술 혁신에 집중하고 있습니다. 이 툴들은 개별 환자 데이터를 분석하여 보다 개인화된 치료 결정을 지원하기 위해 설계된 디지털 시스템입니다. 예를 들어 2023년 8월 미국 의료기술 기업 GE헬스케어 테크놀러지스는 심방세동 환자들의 워크플로우를 효율화하고, 심방세동 환자를 위한 맞춤형 치료를 지원하기 위해 개발된 디지털 임상 의사결정 지원 툴 'CardioVisio for Atrial Fibrillation'을 발표했습니다. Atrial Fibrillation'을 발표했습니다. 본 툴은 과거 진단, 치료, 투약, 관련 질환 정보를 통합하여 심방세동의 진행 상황을 시각화합니다. 또한 확립된 가이드라인에 기반한 치료 권고안을 제공함으로써 진단 오류의 가능성을 줄이고 보다 효율적인 임상적 의사결정을 촉진합니다. CardioVisio는 분산된 환자 데이터를 통합하고 접근하기 쉬운 형태로 제공함으로써 의료 전문가가 심방세동을 보다 효과적이고 효율적으로 관리할 수 있도록 돕습니다.

자주 묻는 질문

  • 심방세동 치료 기기 시장 규모는 어떻게 변화하고 있나요?
  • 심방세동 치료 기기 시장의 성장 요인은 무엇인가요?
  • 심혈관 질환의 증가가 심방세동 치료 기기 시장에 미치는 영향은 무엇인가요?
  • 심방세동 치료 기기 시장의 주요 기업들은 어떤 기술 혁신에 집중하고 있나요?

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA 26.03.05

Atrial fibrillation (AFib) devices are medical technologies developed to detect, monitor, or treat atrial fibrillation, a prevalent heart rhythm disorder characterized by irregular beating of the heart's upper chambers. These devices include implantable cardiac monitors, pacemakers, defibrillators, catheter ablation systems, and wearable electrocardiogram (ECG) monitors. The primary objective of AFib devices is to restore normal heart rhythm, minimize stroke risk, and enhance quality of life.

The main types of atrial fibrillation devices include implantable devices, external devices, and catheter-based devices. Implantable devices refer to tools such as pacemakers, implantable cardioverter defibrillators (ICDs), and implantable loop recorders, which are surgically placed within the body to monitor, regulate, or correct heart rhythm by delivering electrical impulses or continuously recording cardiac activity. These devices are used across various applications, including electrophysiology ablation catheters, cardiac monitors or implantable loop recorders, electrophysiology diagnostic catheters, mapping and recording systems, access devices, intracardiac echocardiography, left atrial appendage closure devices, and other related tools. They operate using technologies such as radiofrequency, cryotherapy, ultrasound, and other advanced methods. Distribution channels include direct sales, distributors, and online platforms, serving end users such as hospitals, cardiac centers, ambulatory surgical centers, and other healthcare providers.

Tariffs have influenced the atrial fibrillation devices market by increasing costs for imported electronic components, ablation catheters, and imaging systems used in device manufacturing. Catheter-based devices and implantable devices are most affected, particularly in regions such as Asia-Pacific and Europe that rely on cross-border supply chains. These tariffs have led to higher device prices and procurement delays for hospitals and cardiac centers. However, they have also encouraged localized manufacturing, supplier diversification, and cost-optimized device development to strengthen regional market resilience.

The atrial fibrillation devices market research report is one of a series of new reports from The Business Research Company that provides atrial fibrillation devices market statistics, including atrial fibrillation devices industry global market size, regional shares, competitors with a atrial fibrillation devices market share, detailed atrial fibrillation devices market segments, market trends and opportunities, and any further data you may need to thrive in the atrial fibrillation devices industry. This atrial fibrillation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The atrial fibrillation devices market size has grown rapidly in recent years. It will grow from $8.6 billion in 2025 to $9.61 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to increasing prevalence of atrial fibrillation, rising geriatric population, growth in cardiovascular disease burden, expansion of electrophysiology labs, adoption of implantable cardiac devices.

The atrial fibrillation devices market size is expected to see rapid growth in the next few years. It will grow to $14.77 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to advancements in ablation technologies, increasing use of remote patient monitoring, rising awareness of stroke prevention, expansion of ambulatory surgical centers, technological innovation in mapping and navigation systems. Major trends in the forecast period include rising adoption of catheter ablation procedures, growing use of wearable and remote ecg monitoring devices, increasing demand for minimally invasive afib treatments, expansion of left atrial appendage closure device usage, improved focus on early detection and long-term rhythm monitoring.

The increasing burden of cardiovascular diseases is expected to drive the growth of the atrial fibrillation device market in the coming years. Cardiovascular diseases encompass conditions that affect the heart and blood vessels, such as heart attacks, strokes, and hypertension. The growing prevalence of these conditions is largely attributed to rising global rates of obesity and diabetes, combined with sedentary lifestyles and unhealthy eating habits. Atrial fibrillation (AFib) devices are essential for managing cardiovascular diseases by detecting, monitoring, and treating irregular heart rhythms, which are frequently linked to underlying heart problems. For example, in June 2024, the American Heart Association, a US-based public health organization, reported that as the prevalence of high blood pressure is projected to increase from 51.2% to 61.0%, the number of individuals diagnosed with cardiovascular diseases is expected to grow from 128 million in 2020 to over 184 million by 2050. Thus, the rising incidence of cardiovascular diseases is contributing to the expansion of the atrial fibrillation device market.

Key players in the atrial fibrillation devices market are focusing on technological advancements, such as patient-centric clinical decision support tools, to improve diagnostic accuracy, customize treatment strategies, and enhance patient outcomes. These tools are digital systems designed to assist healthcare providers by analyzing individual patient data to inform more personalized care decisions. For instance, in August 2023, GE HealthCare Technologies Inc., a US-based medical technology company, introduced CardioVisio for Atrial Fibrillation, a digital clinical decision support tool created to streamline clinician workflows and support targeted care for AFib patients. The tool helps visualize AFib progression, incorporating previous diagnoses, treatments, medications, and related conditions. It also provides therapy recommendations based on established guidelines, reducing the likelihood of diagnostic errors and facilitating more efficient clinical decision-making. CardioVisio consolidates scattered patient data into an accessible format, helping medical professionals manage atrial fibrillation more effectively and efficiently.

In November 2023, Johnson & Johnson MedTech, a US-based medical technology firm, acquired Laminar Inc. for an undisclosed amount. This acquisition aims to enhance Johnson & Johnson MedTech's position in the atrial fibrillation device sector and broaden its range of solutions focused on stroke prevention and cardiac care. Laminar Inc. is a US-based company specializing in the development of innovative devices for left atrial appendage elimination, which are used to prevent strokes in patients with atrial fibrillation.

Major companies operating in the atrial fibrillation devices market are Johnson And Johnson Services Inc, Abbott Laboratories, Medtronic Public Limited Company, Koninklijke Philips NV, Boston Scientific Corporation, Shanghai MicroPort EP MedTech Co Ltd, Japan Lifeline Co Ltd, AliveCor Inc, CardioFocus Inc, Imricor Medical Systems Inc, Kardium Inc, Stereotaxis Inc, Volta Medical, Osypka AG, CathRx Ltd, BIOTRONIK SE And Co KG, EP Solutions SA, CardiacSense Ltd, Biosense Webster Inc, Abbott Electrophysiology, Medtronic Cardiac Rhythm And Heart Failure, Boston Scientific Electrophysiology

North America was the largest region in the atrial fibrillation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial fibrillation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the atrial fibrillation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The atrial fibrillation devices market consists of revenues earned by entities providing services such as diagnostic services, therapeutic services, and patient monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The atrial fibrillation devices market also includes sales of cryoablation catheters, laser ablation systems, and hybrid ablation systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Atrial Fibrillation Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses atrial fibrillation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for atrial fibrillation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The atrial fibrillation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Device Type: Implantable Devices; External Devices; Catheter-Based Devices
  • 2) By Product: Electrophysiology Ablation Catheters; Cardiac Monitors Or Implantable Loop Recorder; Electrophysiology Diagnostic Catheters; Mapping And Recording Systems; Access Devices; Intracardiac Echocardiography; Left Atrial Appendage Closure Devices; Other Products
  • 3) By Technology: Radiofrequency; Cryotherapy; Ultrasound; Other Technologies
  • 4) By Distribution Channel: Direct Sales; Distributors; Online Sales
  • 5) By End-Use: Hospitals; Cardiac Centers; Ambulatory Surgical Centers; Other End Users
  • Subsegments:
  • 1) By Implantable Devices: Implantable Cardioverter Defibrillators; Pacemakers; Insertable Cardiac Monitors
  • 2) By External Devices: External Defibrillators; Holter Monitors; Mobile Cardiac Telemetry Devices; Electrocardiogram Monitors
  • 3) By Catheter-Based Devices: Radiofrequency Ablation Catheters; Cryoablation Catheters; Laser Ablation Catheters; Mapping and Navigation Systems; Transseptal Access Devices
  • Companies Mentioned: Johnson And Johnson Services Inc; Abbott Laboratories; Medtronic Public Limited Company; Koninklijke Philips NV; Boston Scientific Corporation; Shanghai MicroPort EP MedTech Co Ltd; Japan Lifeline Co Ltd; AliveCor Inc; CardioFocus Inc; Imricor Medical Systems Inc; Kardium Inc; Stereotaxis Inc; Volta Medical; Osypka AG; CathRx Ltd; BIOTRONIK SE And Co KG; EP Solutions SA; CardiacSense Ltd; Biosense Webster Inc; Abbott Electrophysiology; Medtronic Cardiac Rhythm And Heart Failure; Boston Scientific Electrophysiology
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Atrial Fibrillation Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Atrial Fibrillation Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Atrial Fibrillation Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Atrial Fibrillation Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Catheter Ablation Procedures
    • 4.2.2 Growing Use Of Wearable And Remote Ecg Monitoring Devices
    • 4.2.3 Increasing Demand For Minimally Invasive Afib Treatments
    • 4.2.4 Expansion Of Left Atrial Appendage Closure Device Usage
    • 4.2.5 Improved Focus On Early Detection And Long-Term Rhythm Monitoring

5. Atrial Fibrillation Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Cardiac Centers
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Specialty Cardiology Clinics
  • 5.5 Research And Academic Institutes

6. Atrial Fibrillation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Atrial Fibrillation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Atrial Fibrillation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Atrial Fibrillation Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Atrial Fibrillation Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Atrial Fibrillation Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Atrial Fibrillation Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Atrial Fibrillation Devices Market Segmentation

  • 9.1. Global Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable Devices, External Devices, Catheter-Based Devices
  • 9.2. Global Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Electrophysiology Ablation Catheters, Cardiac Monitors Or Implantable Loop Recorder, Electrophysiology Diagnostic Catheters, Mapping And Recording Systems, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices, Other Products
  • 9.3. Global Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Radiofrequency, Cryotherapy, Ultrasound, Other Technologies
  • 9.4. Global Atrial Fibrillation Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Direct Sales, Distributors, Online Sales
  • 9.5. Global Atrial Fibrillation Devices Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Other End Users
  • 9.6. Global Atrial Fibrillation Devices Market, Sub-Segmentation Of Implantable Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable Cardioverter Defibrillators, Pacemakers, Insertable Cardiac Monitors
  • 9.7. Global Atrial Fibrillation Devices Market, Sub-Segmentation Of External Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • External Defibrillators, Holter Monitors, Mobile Cardiac Telemetry Devices, Electrocardiogram Monitors
  • 9.8. Global Atrial Fibrillation Devices Market, Sub-Segmentation Of Catheter-Based Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Radiofrequency Ablation Catheters, Cryoablation Catheters, Laser Ablation Catheters, Mapping and Navigation Systems, Transseptal Access Devices

10. Atrial Fibrillation Devices Market Regional And Country Analysis

  • 10.1. Global Atrial Fibrillation Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Atrial Fibrillation Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Atrial Fibrillation Devices Market

  • 11.1. Asia-Pacific Atrial Fibrillation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Atrial Fibrillation Devices Market

  • 12.1. China Atrial Fibrillation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Atrial Fibrillation Devices Market

  • 13.1. India Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Atrial Fibrillation Devices Market

  • 14.1. Japan Atrial Fibrillation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Atrial Fibrillation Devices Market

  • 15.1. Australia Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Atrial Fibrillation Devices Market

  • 16.1. Indonesia Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Atrial Fibrillation Devices Market

  • 17.1. South Korea Atrial Fibrillation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Atrial Fibrillation Devices Market

  • 18.1. Taiwan Atrial Fibrillation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Atrial Fibrillation Devices Market

  • 19.1. South East Asia Atrial Fibrillation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Atrial Fibrillation Devices Market

  • 20.1. Western Europe Atrial Fibrillation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Atrial Fibrillation Devices Market

  • 21.1. UK Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Atrial Fibrillation Devices Market

  • 22.1. Germany Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Atrial Fibrillation Devices Market

  • 23.1. France Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Atrial Fibrillation Devices Market

  • 24.1. Italy Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Atrial Fibrillation Devices Market

  • 25.1. Spain Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Atrial Fibrillation Devices Market

  • 26.1. Eastern Europe Atrial Fibrillation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Atrial Fibrillation Devices Market

  • 27.1. Russia Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Atrial Fibrillation Devices Market

  • 28.1. North America Atrial Fibrillation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Atrial Fibrillation Devices Market

  • 29.1. USA Atrial Fibrillation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Atrial Fibrillation Devices Market

  • 30.1. Canada Atrial Fibrillation Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Atrial Fibrillation Devices Market

  • 31.1. South America Atrial Fibrillation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Atrial Fibrillation Devices Market

  • 32.1. Brazil Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Atrial Fibrillation Devices Market

  • 33.1. Middle East Atrial Fibrillation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Atrial Fibrillation Devices Market

  • 34.1. Africa Atrial Fibrillation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Atrial Fibrillation Devices Market, Segmentation By Device Type, Segmentation By Product, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Atrial Fibrillation Devices Market Regulatory and Investment Landscape

36. Atrial Fibrillation Devices Market Competitive Landscape And Company Profiles

  • 36.1. Atrial Fibrillation Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Atrial Fibrillation Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Atrial Fibrillation Devices Market Company Profiles
    • 36.3.1. Johnson And Johnson Services Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medtronic Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Atrial Fibrillation Devices Market Other Major And Innovative Companies

  • Shanghai MicroPort EP MedTech Co Ltd, Japan Lifeline Co Ltd, AliveCor Inc, CardioFocus Inc, Imricor Medical Systems Inc, Kardium Inc, Stereotaxis Inc, Volta Medical, Osypka AG, CathRx Ltd, BIOTRONIK SE And Co KG, EP Solutions SA, CardiacSense Ltd, Biosense Webster Inc, Abbott Electrophysiology

38. Global Atrial Fibrillation Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Atrial Fibrillation Devices Market

40. Atrial Fibrillation Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Atrial Fibrillation Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Atrial Fibrillation Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Atrial Fibrillation Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제